Biostar Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Four
Biostar Pharmaceuticals, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $585.65 thousand as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2017-11-20
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $585.65K.
- 2017-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $574.46K.
- 2017-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $108.28K.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $107.44K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Four |
|---|---|
| 2017-09-30 | $585.65K 10-Q · filed 2017-11-20 |
| 2017-06-30 | $574.46K 10-Q · filed 2017-11-15 |
| 2017-03-31 | $108.28K 10-Q · filed 2017-05-19 |
| 2016-12-31 | $107.44K 10-K · filed 2017-04-13 |
| 2016-09-30 | $577.36K 10-Q · filed 2016-11-21 |
| 2016-06-30 | $584.34K 10-Q · filed 2016-08-22 |
| 2016-03-31 | $612.13K 10-Q · filed 2016-05-23 |
| 2015-12-31 | $1.07M 10-K · filed 2016-04-14 |
| 2015-09-30 | $1.20M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $1.25M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $1.24M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.24M 10-K · filed 2015-04-15 |
| 2014-09-30 | $1.59M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $1.45M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.04M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.11M 10-K · filed 2014-03-31 |
| 2013-09-30 | $2.23M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.08M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $1.39M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.36M 10-K · filed 2013-04-15 |
| 2012-09-30 | $1.37M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $1.37M 10-Q · filed 2012-08-14 |